Collaboration Overview. Subject to Section 2.4, the Parties shall initiate at least [**] research programs each Research Term Year focused on the discovery and research of products directed to Research Targets utilizing Carisma Technology for use in the Field (each, a “Research Program”), including [**] Research Programs to be initiated within [**] following the effectiveness of the Agreement, with the objective of Moderna evaluating [**] Products in Clinical Trials and potentially obtaining Marketing Approval therefor by performing the activities set forth in the Research Plans (the “Collaboration”).
Appears in 3 contracts
Sources: Collaboration and License Agreement (Carisma Therapeutics Inc.), Collaboration and License Agreement (Sesen Bio, Inc.), Collaboration and License Agreement (Sesen Bio, Inc.)